Stephen Oesterle

Alcyone Therapeutics, Inc. develops novel treatment modalities for difficult neurological conditions. The company was founded by Paramjith Anand, Adam S. Fleisher, Corey M. McCann, and William L. Olbricht in 2010 and is headquartered in Lowell, MA.

CeramTec GmbH engages in the development, manufacture, and sale of parts, components and products made from ceramic materials. Its products include dental ceramics; dielectric and capacitors; bearings and sealing technology; circuit carrier; forming processes; heat-sinks; hermetically sealed components; joint replacement; and machining applications. The company was founded in 1996 and is headquartered in Plochingen, Germany.

The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA.

New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.

Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA.

REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA.

GlobalLogic, Inc. provides software solutions and development services. It operates as a digital product engineering firm. Its services include experience design, product engineering, digital services, labs, and content engineering. The firm operates design studios and engineering centers that specializes in offering customers in the communications, automotive, healthcare, technology, media and entertainment, manufacturing, and semiconductor industries. The company was founded by Sanjay Singh, Manoj Agarwala, Rajul Garg, and Tarun Upadhyay in 2000 and is headquartered in San Jose, CA.

New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group.

InCube Ventures Partners LLC (InCube Ventures) is a venture capital firm founded in 2008 by Mir Imran. The firm is headquartered in San Jose, California.

HeartWare International LLC is a medical device company, which engaged in the development and manufacturing of miniaturized implantable heart pumps or ventricular assist devices to treat patients suffering from advanced heart failure. The company was founded on July 29, 2008 and is headquartered in Framingham, MA.

Baxter SpA engages in providing therapies for the treatment of serious and chronic diseases. The company is headquartered in Rome, Italy.

MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France.

Part of Baxter International, Inc., Baxter Healthcare Ltd. is a company based in Newbury, UK. Baxter Healthcare Ltd. helps maximize safety, streamline processes, and build cost efficiency throughout the hospital, from the pharmacy to the bedside. The British company was founded in 1948. José E. Almeida has been the CEO of the company since 2016.

SmartZyme Biopharma, Inc. provides platform for protein design and engineering in accordance with industry required specifications. The company was founded by David Baram and Shilo Ben Zeev in 2013 and is headquartered in Ness Ziona, Israel.

CBC Group (Singapore) Pte. Ltd.(CBC Group) is a private equity firm founded in 2014 by Wei Fu. The firm is headquartered in Singapore with additional offices in New York, Hong Kong, Shanghai and Beijing and is wholly owned by CBC Group Investment Management Ltd.

SHL Medical AG engages in the design, development, and manufacture of advanced drug delivery devices, as well as provides final assembly, labeling, and packaging services for pharma and biotech companies. Its products include autoinjectors, pen injectors, inhaler systems, pressure mattress systems, patient lifting slings, medical soft goods. The firm also offers design-to-build and contract manufacturing of products, such as laboratory handling equipment, neurosurgical devices, and industrial equipment. The company was founded by Roger Samuelsson and Martin Jelf in 1989 and is headquartered in Zug, Switzerland.

Patient Square Capital is an Independent Private Equity/Venture Capital firm founded by Jim Momtazee and Maria Walker. Patient Square Capital is headquartered in Menlo Park.

Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA.

Anuncia, Inc. develops neuro therapeutic devices. The American company was founded in 2018. Elsa Chi Abruzzo has been the CEO of the company since 2018.

Baxter Healthcare Pty Ltd. develops, manufactures, and markets products that save and sustain the lives of people with haemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It offers biopharmaceuticals and medical equipment. The company was founded in 1963 and is headquartered in Old Toongabbie, Australia.

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.